Abstract Title:

Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.

Abstract Source:

J Neuropathol Exp Neurol. 2004 Sep;63(9):956-63. PMID: 15453094

Abstract Author(s):

Emmanuel Contassot, Rick Wilmotte, Mirna Tenan, Marie-Claude Belkouch, Valérie Schnüriger, Nicolas de Tribolet, Karim Burkhardt, Pierre-Yves Dietrich, Karim Bourkhardt

Article Affiliation:

Laboratory of Tumor Immunology, University Hospital, Geneva, Switzerland.

Abstract:

The anti-tumor properties of cannabinoids have recently been evidenced, mainly with delta9-tetrahydrocannabinol (THC). However, the clinical application of this drug is limited by possible undesirable side effects due to a broad expression of cannabinoid receptors (CB1 and CB2). An attractive field of research therefore is to identify molecules with more selective tumor targeting. This is particularly important for malignant gliomas, considering their poor prognosis and their location in the brain. Here we investigated whether the most potent endogenous cannabinoid, arachidonylethanolamide (AEA), could be a candidate. We observed that AEA induced apoptosis in long-term and recently established glioma cell lines via aberrantly expressed vanilloid receptor-1 (VR1). In contrast with their role in THC-mediated death, both CB1 and CB2 partially protected glioma against AEA-induced apoptosis. These data show that the selective targeting of VR1 by AEA or more stable analogues is an attractive research area for the treatment of glioma.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.